DNA insider trading
NYSE HealthcareGinkgo Bioworks Holdings, Inc.: insider trade history from SEC Form 4 filings.
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Company website: www.ginkgo.bio
DNA insider activity at a glance
FilingIQ tracks 1,016 insider transactions for DNA in filings since Sep 20, 2021. The most recent transaction is dated Sep 15, 2026.
Across the full history, 4 open-market purchases
and 771 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on DNA insider trades is 55.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest DNA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding DNA
Frequently asked
- How many insider trades does FilingIQ track for DNA?
- FilingIQ tracks 1,016 Form 4 insider transactions for DNA (Ginkgo Bioworks Holdings, Inc.), covering filings from Sep 20, 2021 onwards. 7 of those are dated within the last 90 days.
- Are DNA insiders net buyers or net sellers?
- Across the full Form 4 history for DNA, 4 transactions (0%) were open-market purchases and 771 (76%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DNA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is DNA in?
- Ginkgo Bioworks Holdings, Inc. (DNA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $401.89M.
Methodology & sources
Every DNA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.